Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.1.1.21 extracted from

  • Da Settimo, F.; Primofiore, G.; La Motta, C.; Salerno, S.; Novellino, E.; Greco, G.; Lavecchia, A.; Laneri, S.; Boldrini, E.
    Spirohydantoin derivatives of thiopyrano[2,3-b]pyridin-4(4H)-one as potent in vitro and in vivo aldose reductase inhibitors (2005), Bioorg. Med. Chem., 13, 491-499.
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
2,3-dihydrospiro[4H-thiopyrano[2,3-b]pyridin-4,4'imidazolidine]-2',5'-dione 50% inhibition at 0.0034 mM Rattus norvegicus
2,3-dihydrospiro[4H-thiopyrano[2,3-b]pyridin-4,4'imidazolidine]-2',5'-dione, sulfone derivative 50% inhibition at 0.0014 mM Rattus norvegicus
7-methyl-2,3-dihydrospiro[4H-thiopyrano[2,3-b]pyridin-4,4'imidazolidine]-2',5'-dione 50% inhibition at 0.0011 mM Rattus norvegicus
additional information model of inhibitor binding interactions Rattus norvegicus
N-acetyl-2,3-dihydrospiro[4H-thiopyrano[2,3-b]pyridin-4,4'imidazolidine]-2',5'-dione 50% inhibition at 0.050 mM Rattus norvegicus
quercetin
-
Rattus norvegicus
sorbinil 50% inhibition at 29 nM Rattus norvegicus

Organism

Organism UniProt Comment Textmining
Rattus norvegicus
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
lens
-
Rattus norvegicus
-